# A Study of RGLS8429 in Healthy Volunteers

> **NCT05429073** · PHASE1 · COMPLETED · sponsor: **Regulus Therapeutics Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** RGLS8429
- **DRUG:** Placebo volume-matching RGLS8429 dose

## Key facts

- **NCT ID:** NCT05429073
- **Lead sponsor:** Regulus Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-10
- **Primary completion:** 2022-09-08
- **Final completion:** 2022-09-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429073, "A Study of RGLS8429 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05429073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*